Swedbank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.3M | Buy |
|
|||||
|
2025
Q2 | $23.7M | Buy |
|
|||||
|
2025
Q1 | $30.4M | Sell |
|
|||||
|
2024
Q4 | $28.4M | Buy |
|
|||||
|
2024
Q3 | $27.3M | Buy |
|
|||||
|
2024
Q2 | $23.8M | Sell |
|
|||||
|
2024
Q1 | $25.9M | Sell |
|
|||||
|
2023
Q4 | $45M | Sell |
|
|||||
|
2023
Q3 | $44.9M | Hold |
|
|||||
|
2023
Q2 | $43.9M | Hold |
|
|||||
|
2023
Q1 | $49.3M | Buy |
|
|||||
|
2022
Q4 | $46.3M | Buy |
|
|||||
|
2022
Q3 | $35.7M | Sell |
|
|||||
|
2022
Q2 | $43.8M | Buy |
|
|||||
|
2022
Q1 | $38.9M | Buy |
|
|||||
|
2021
Q4 | $28.6M | Sell |
|
|||||
|
2021
Q3 | $26M | Buy |
|
|||||
|
2021
Q2 | $12M | Hold |
|
|||||
|
2021
Q1 | $10.9M | Buy |
|